Physician profile
John Terrill Main
NPI 1467405233
$2,782,816.04
in general payments reported to CMS, 2019-2025
19 companies · $531K in 2025
The $531K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $30.92 · 2021: $636K · 2022: $636K · 2023: $618K · 2024: $361K · 2025: $531K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $890K · Acquisitions: $618K · Food and Beverage: $1,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $890,000.00 |
| Acquisitions | $618,000.00 |
| Food and Beverage | $1,716.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnia Medical, LLC | $2,780,000.00 | 2021-2025 | |
| Orthofix Medical, INC. | $638.75 | 2019-2025 | Spinal-Stim, Northstar, Explorer To |
| Ulrich Medical USA, INC. | $431.22 | 2022-2023 | |
| Spinal Elements, INC. | $344.78 | 2025 | |
| Medtronic, INC. | $324.25 | 2024-2025 | Mazor X System, Catalyft Pl Expandable Interbody System |
| Republic Spine | $230.45 | 2024 | Dark Star |
| Centinel Spine, LLC | $154.76 | 2019 | |
| Nevro Corp. | $115.45 | 2019 | |
| Integrity Implants INC. | $101.04 | 2022 | |
| Depuy Synthes Sales INC. | $98.36 | 2019-2024 | Trumatch, Synthecel |
| Abbott Laboratories | $75.50 | 2022 | |
| Medtronic USA, INC. | $75.00 | 2019 | |
| Boston Scientific Corporation | $54.99 | 2022-2024 | |
| Stimwave Technologies Incorporated | $51.00 | 2021 | |
| Augmedics INC. | $40.55 | 2024 | Xvision |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $28.24 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.74 | 2021 | |
| Misonix INC | $19.56 | 2019 | |
| Stryker Corporation | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Main listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.